Integrity of intestinal anastomoses following muscle relaxant reversal with neostigmine.
D000328:Adult; D000368:Aged; D000765:Anesthesia, Conduction; D000769:Anesthesia, Inhalation; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D003082:Colectomy; D003125:Colostomy; D003521:Cyclopropanes; D005019:Ethyl Ethers; D005260:Female; D006221:Halothane; D006801:Humans; D007422:Intestines / Q000601:surgery*; D007441:Intubation, Gastrointestinal; D008297:Male; D008733:Methoxyflurane; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009388:Neostigmine / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D009609:Nitrous Oxide; D011183:Postoperative Complications / Q000139:chemically induced*; D012189:Retrospective Studies
D003521:Cyclopropanes; D005019:Ethyl Ethers; D009467:Neuromuscular Depolarizing Agents; D008733:Methoxyflurane; D009388:Neostigmine; D001285:Atropine; D009609:Nitrous Oxide; D006221:Halothane